W
WuXi Bo Rui
A radioactive molecular imaging and nuclear drug transformation platform
About WuXi Bo Rui
BoomRay is a pioneering company in the nuclear medicine industry, focusing on the development of proprietary diagnostic and therapeutic radionuclide drugs. The company serves the healthcare sector, particularly hospitals and medical research institutions, by providing advanced nuclear medicine solutions. Operating primarily in the Chinese market, BoomRay leverages its strong ties with Peking University and collaborations with various hospitals to drive innovation and industrial translation of its research. The business model revolves around the research, development, and commercialization of radionuclide drugs, generating revenue through product sales and licensing agreements. BoomRay has successfully secured significant funding, including a nearly RMB300 million Series A financing in 2022, led by Sequoia China and other prominent investors. The company boasts a management team with extensive experience in nuclear medicine and drug design, further strengthening its position in the market. Key milestones include the establishment of an R&D center with animal facilities and radiochemistry labs in Suzhou, and the approval of its first Investigational New Drug (IND) in both China and the US in 2023.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Sep 2022 | $41M | $165M | Sequoia · Puhua Capital · HSG · River Head Capital | ↗ |
Growth signals
Latest recorded traffic for WuXi Bo Rui is 800 monthly website visits, up 35.6% over the last three months. WuXi Bo Rui's team grew 25% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
WuXi Bo Rui in its local ecosystem
The WuXi Bo Rui office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Sequoia- PCPuhua Capital
HSG
River Head Capital
Tsing Song Capital- TCTririver Capital
- LCLife Garden Venture Capital
- JEJinsheng Equity
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about WuXi Bo Rui on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See WuXi Bo Rui’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









